Dysmenorrhea
📧 Sign up to get email alerts when something new happens for Dysmenorrhea.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-30FDA Approved: CELECOXIB — Original Application (Micro Labs Limited)
FDA approved the original generic application for celecoxib from Micro Labs Limited, providing a generic celecoxib option aligned with the r…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea [NA]
A behavioral intervention trial investigating pain catastrophizing in primary dysmenorrhea has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation [NA]
A completed clinical trial sponsored by Loma Linda University evaluated whether daily ginger tea reduces discomfort during menstruation.
-
FDA approval · 2018-03-27FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental NDA for ALEVE GELCAPS (naproxen sodium) by Bayer HealthCare LLC. The approval adds a gel-cap dosage form for thi…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: TENS on Pain Intensity in Primary Dysmenorrhea [NA]
This clinical trial evaluating transcutaneous electrical nerve stimulation (TENS) for reducing pain in primary dysmenorrhea has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-08Clinical Trial Update: Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis [Phase 4]
Phase 4 trial evaluating the effect of ulipristal acetate on bleeding patterns and dysmenorrhea in women with adenomyosis; the study status …
-
FDA approval · 2018-01-23FDA Approved: CELECOXIB — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' generic celecoxib as an Original Application (ANDA210071), enabling market entry for this COX-2 in…
-
FDA approval · 2017-12-21FDA Approved: DOLEX FLEX — Original Application (Pharmadel LLC)
FDA approved DOLEX FLEX (ibuprofen) through Pharmadel LLC's original ANDA.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Preemptive Analgesia for Primary Dysmenorrhoea [Phase 2, Phase 3]
Phase 2 and Phase 3 trial update for preemptive analgesia in primary dysmenorrhea.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059) [Phase 3]
Phase 3 trial evaluating the etonogestrel + 17β-estradiol vaginal ring for moderate-to-severe primary dysmenorrhea was terminated, and resul…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of the etonogestrel + 17β-estradiol vaginal ring for treating primary dysmenorrhea; results…
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: Application of Electrical Neurostimulation Transcutaneous in Patients With Primary Dysmenorrhea. [NA]
A clinical trial evaluating transcutaneous electrical neurostimulation for primary dysmenorrhea has completed. The study is sponsored by Uni…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea [NA]
This clinical trial comparing electromagnetic field therapy with diclofenac for primary dysmenorrhea has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057) [Phase 2]
Phase 2 study evaluating a contraceptive vaginal ring for primary dysmenorrhea has completed with results posted in 2017.
-
FDA approval · 2017-08-22FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for ALEVE GELCAPS (naproxen sodium) by Bayer HealthCare LLC., expanding the product through a supple…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Drotaverine in Dysmenorrhoea Treatment [Phase 4]
The Phase 4 trial evaluating drotaverine for dysmenorrhea has been terminated.
-
FDA approval · 2017-06-22FDA Approved: INDOMETHACIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Indomethacin generic under an Original Application; this entry records the approval status and product details.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Pulse Diagnoses in Patients While Dysmenorrhea is Attacking
A clinical trial evaluating pulse diagnosis in patients with dysmenorrhea sponsored by Taipei Hospital, Taiwan has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea [Phase 1, Phase 2]
Phase 1/2 trial evaluating continuous administration of a combined oral contraceptive for primary dysmenorrhea. The study is completed with …
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Treatment Choice in Primary Dysmenorrhea [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating treatment choice for primary dysmenorrhea.
-
FDA approval · 2017-03-10FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen by Zameer Pharmaceuticals LLC.
-
FDA approval · 2017-01-23FDA Approved: NAPROXEN — Original Application (Amerisource Bergen)
FDA approves AmerisourceBergen's original application for naproxen sodium tablets, a generic naproxen product.
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea [Phase 3]
Phase 3 trial update for Treximet (sumatriptan/naproxen) evaluating menstrual migraine in women with dysmenorrhea; the study has completed.
-
FDA approval · 2016-09-16FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for celecoxib (generic) under ANDA204197.
-
FDA approval · 2016-09-14FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for CELECOXIB from Aurobindo Pharma Limited (ANDA206827). This notice confirms the supplemental appr…